- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
Status
Ongoing
Phase
Other
Principal Investigator(s)
Sydney Rosen
Objective
Rapid intitiation of antiretroviral therapy to promote early HIV/AIDS treatment in South Africa (RapIT).
Evaluation of the feasibility, effectivenessm, and cost-effectiveness of rapid ART initiation.
Prevention Option(s)
Treatment
Study Design
Randomized
Open label
Arms and Assigned Interventions
Description
No Intervention: Standard group, non-pregnant adults
Comparison group (prospective enrolment)
ARMs
Placebo Comparator
Description
No Intervention: Standard group, pregnant women
Comparison group (retrospective record review)
ARMs
Placebo Comparator
Description
Rapid group, non-pregnant adults
Rapid ART initiation
ARMs
Experimental
Description
Rapid group, pregnant women
Rapid ART initiation
ARMs
Experimental
Official Code
Trial Sponsors
Boston University, NIAID, & University of Witwatersrand, South Africa
May 2014
May 2015
Enrollment
600
18
Years
Population
Women
Men
HIV positive
Sites
Thuthukani Primary Health Clinic
Johannesburg, Gauteng
South Africa
Themba Lethu Clinic, Helen Joseph Hospital
Johannesburg, Guateng
South Africa